Cargando…

Interleukin-35 as a predictor of prostate cancer in patients undergoing initial prostate biopsy

BACKGROUND: Interleukin (IL)-35 is a novel inhibitory cytokine and has recently been implicated in tumor immunity. However, the role of IL-35 in prostate cancer (PCa) has not been elucidated. OBJECTIVE: To evaluate the role of plasma IL-35 in the diagnosis and prognosis of PCa in Chinese patients un...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Chenchao, Zhang, Jun, Chen, Ye, Wang, Hao, Hou, Jianquan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522820/ https://www.ncbi.nlm.nih.gov/pubmed/28761357 http://dx.doi.org/10.2147/OTT.S135873

Ejemplares similares

PSCA rs1045531 Polymorphism and the Risk of Prostate Cancer in a Chinese Population Undergoing Prostate Biopsy
por: Zhang, Xuefeng, et al.
Publicado: (2017)

Interleukin-35 is associated with the tumorigenesis and progression of prostate cancer
por: Zhu, Jialin, et al.
Publicado: (2019)

Performance characteristics of prostate-specific antigen density and biopsy primary Gleason score to predict biochemical failure in patients with intermediate prostate cancer who underwent radical prostatectomy
por: Peng, Chao, et al.
Publicado: (2019)

Indications for a second prostate biopsy in patients suspected with prostate cancer after an initial negative prostate biopsy
por: Lee, Kwang Suk, et al.
Publicado: (2017)

Comparison of MRI/US Fusion Targeted Biopsy and Systematic Biopsy in Biopsy-Naïve Prostate Patients with Elevated Prostate-Specific Antigen: A Diagnostic Study
por: Huang, Chen, et al.
Publicado: (2022)

Prostate cancer antigen 3 moderately improves diagnostic accuracy in Chinese patients undergoing first prostate biopsy
por: Wang, Fu-Bo, et al.
Publicado: (2017)

Interleukin-35 promotes progression of prostate cancer and inhibits anti-tumour immunity
por: Zhu, Jialin, et al.
Publicado: (2020)

Prostatic chronic inflammation and prostate cancer risk at baseline random biopsy: Analysis of predictors
por: Tafuri, Alessandro, et al.
Publicado: (2020)

Serum Adipokines as Predictors for the Outcome of Prostate Biopsies at Early Stage Prostate Cancer Diagnosis
por: Ahmad, Ardalan E, et al.
Publicado: (2019)

Anterior prostate biopsy at initial and repeat evaluation: is it useful to detect significant prostate cancer?
por: Pepe, Pietro, et al.
Publicado: (2015)

Optimizing the clinical utility of PCA3 to diagnose prostate cancer in initial prostate biopsy
por: Rubio-Briones, Jose, et al.
Publicado: (2015)

Development and internal validation of a prediction model of prostate cancer on initial transperineal template-guided prostate biopsy
por: Chen, Yuliang, et al.
Publicado: (2021)

Predictors of Clinically Significant Prostate Cancer in Patients with PIRADS Categories 3–5 Undergoing Magnetic Resonance Imaging-Ultrasound Fusion Biopsy of the Prostate
por: Szempliński, Stanisław, et al.
Publicado: (2022)

Correlation between body mass index (BMI) and the Gleason score of prostate biopsies in Chinese population
por: Zhou, Feng, et al.
Publicado: (2016)

MultiParametric Magnetic Resonance Imaging-Based Nomogram for Predicting Prostate Cancer and Clinically Significant Prostate Cancer in Men Undergoing Repeat Prostate Biopsy
por: Huang, Cong, et al.
Publicado: (2018)

Is Additional Systematic Biopsy Necessary in All Initial Prostate Biopsy Patients With Abnormal MRI?
por: Cheng, Xueqing, et al.
Publicado: (2021)

MRI-based radiomics models to assess prostate cancer, extracapsular extension and positive surgical margins
por: He, Dong, et al.
Publicado: (2021)

Elevated Plasma Interleukin-35 as a Prognostic Indicator in Localized Clear Cell Renal Cell Carcinoma
por: Zhang, Jun, et al.
Publicado: (2022)

Absence of Bladder Outlet Obstruction Is an Independent Risk Factor for Prostate Cancer in Men Undergoing Prostate Biopsy
por: Cormio, Luigi, et al.
Publicado: (2016)

Prostate cancer detection rate in men undergoing transperineal template‐guided saturation and targeted prostate biopsy
por: Kaufmann, Basil, et al.
Publicado: (2021)

New Diagnostic Model for Clinically Significant Prostate Cancer in Biopsy-Naïve Men With PIRADS 3
por: Huang, Chen, et al.
Publicado: (2022)

Prostate health index is useful for prostate cancer detecting in Chinese people
por: Huang, Yuhua, et al.
Publicado: (2019)

The use of prostate MR for targeting prostate biopsies
por: Kelley, R. Phelps, et al.
Publicado: (2019)

Cost-Effectiveness Analysis of Prostate Health Index in Decision Making for Initial Prostate Biopsy
por: Huang, Da, et al.
Publicado: (2020)

Application of transrectal ultrasound-guided repeat needle biopsy in the diagnosis of prostate cancer in Chinese population: A retrospective study
por: Wang, Yi, et al.
Publicado: (2016)

Prognostic Significance of Chromogranin A Expression in the Initial and Second Biopsies in Metastatic Prostate Cancer
por: Huang, Zhuo, et al.
Publicado: (2023)

Cribriform pattern in prostate tissues: Predictor for intraductal carcinoma of the prostate based on biopsy and radical prostatectomy pathology
por: Shiomi, Ei, et al.
Publicado: (2022)

Does Prostate Volume Correlate with Vitamin D Deficiency Among Men Undergoing Prostate Biopsy?
por: Murphy, Adam B., et al.
Publicado: (2016)

Magnetic Resonance Imaging–targeted Prostate Biopsy Compared with Systematic Prostate Biopsy in Biopsy-naïve Patients with Suspected Prostate Cancer
por: Alkema, Nicolette G., et al.
Publicado: (2022)

Role of Perilesional Sampling of Patients Undergoing Fusion Prostate Biopsies
por: Lombardo, Riccardo, et al.
Publicado: (2023)

Prostate Cancer Detection at Rebiopsy After an Initial Benign Diagnosis: Results Using Sextant Extended Prostate Biopsy
por: Leite, Katia Ramos Moreira, et al.
Publicado: (2008)

Predictive Factors of Prostate Cancer at Repeat Biopsy in Patients with an Initial Diagnosis of Atypical Small Acinar Proliferation of the Prostate
por: Ryu, Jae Hyun, et al.
Publicado: (2010)

Strain Elastography-Targeted Biopsy: Does Prostate Volume Affect Prostate Cancer Detection?
por: Zhu, Yi-Cheng, et al.
Publicado: (2019)

Predictors of erectile dysfunction after transperineal template prostate biopsy
por: Tan, Jo-Lynn, et al.
Publicado: (2021)

Role of Prostate-Specific Antigen Change Ratio at Initial Biopsy as a Novel Decision-Making Marker for Repeat Prostate Biopsy
por: Lee, Jung Gon, et al.
Publicado: (2012)

The Combined Effect of Polygenic Risk Score and Prostate Health Index in Chinese Men Undergoing Prostate Biopsy
por: Ruan, Xiaohao, et al.
Publicado: (2023)

Performance of transperineal template-guided mapping biopsy in detecting prostate cancer in the initial and repeat biopsy setting
por: Taira, A V, et al.
Publicado: (2009)

Urine Exosomal AMACR Is a Novel Biomarker for Prostate Cancer Detection at Initial Biopsy
por: Jin, Xin, et al.
Publicado: (2022)

Platelet-to-lymphocyte ratio is not a predictor of clinically significant prostate cancer at the prostate biopsy: A large cohort study
por: Lee, Jeong Woo, et al.
Publicado: (2021)

Can we omit systematic biopsies in patients undergoing MRI fusion-targeted prostate biopsies?
por: Leow, Jeffrey J, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7a4nlujh7ocbtbb56cgfur1h6g